Literature DB >> 659881

In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors.

B A Blazar, G H Heppner.   

Abstract

A method of separating lymphoid cells from solid mouse mammary tumors was developed and evaluated. In this method the tumors are digested with 0.01% collagenase, 0.01% DNAase, and 0.025% trypsin in Dulbecco's PBS into suspensions of cells with a viability of 90%. The suspensions are fractionated on a continuous gradient of Ficoll in tissue culture medium. In model experiments this gradient was found to separate, cleanly, admixed cells of an established mammary tumor cell line and dissociated thymus glands. Recovery rates were 50% for the tumor cells and 80% for the thymocytes. The preparation of the cell suspensions and the gradient separation procedure are not harmful to the cells as indicated by trypan blue exclusion and the ability to grow in cell culture.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659881

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Effects of isolated tumor lymphocytes alone and with adherent cells.

Authors:  B A Blazar; N Galili; E Klein
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors.

Authors:  W Z Wei; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 3.  Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.

Authors:  M H Geukes Foppen; M Donia; I M Svane; J B A G Haanen
Journal:  Mol Oncol       Date:  2015-10-30       Impact factor: 6.603

Review 4.  Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV).

Authors:  O Stutman
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties.

Authors:  A M Rios; F R Miller; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Purified mouse mammary tumor and lymphoid cells in immune assays.

Authors:  B A Blazar; F Vanky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.